Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlogl M, Staehelin HB, Willett WC, Dawson-Hughes B. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26(12):2793–802.
Article CAS PubMed Google Scholar
Schaap LA, van Schoor NM, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. J Gerontol A Biol. 2018;73(9):1199–204.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopeni. 2016;7(1):28–36.
Xu J, Wan CS, Ktoris K, Reijnierse EM, Maier AB. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361–76.
Cheng L, Sit J, Chan H, Choi KC, Cheung R, Wong M, Li F, Lee TY, Fung E, Tai KM, et al. Sarcopenia risk and associated factors among Chinese community-dwelling older adults living alone. Sci Rep. 2021;11(1):22219.
Article CAS PubMed PubMed Central Google Scholar
Wong E, Backholer K, Gearon E, Harding J, Freak-Poli R, Stevenson C, Peeters A. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1(2):106–14.
Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33(7):1497–9.
Article PubMed PubMed Central Google Scholar
Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30(6):1507–12.
Leenders M, Verdijk LB, van der Hoeven L, Adam JJ, van Kranenburg J, Nilwik R, van Loon LJ. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc. 2013;14(8):585–92.
Antuña E, Cachán-Vega C, Bermejo-Millo JC, Potes Y, Caballero B, Vega-Naredo I, Coto-Montes A, Garcia-Gonzalez C. Inflammaging: Implications in Sarcopenia. Int J Mol Sci. 2022;23(23):15039.
Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67–81.
Article CAS PubMed Google Scholar
Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–90.
Article PubMed PubMed Central Google Scholar
Sambashivaiah S, Harridge S, Sharma N, Selvam S, Rohatgi P, Kurpad AV. Asian Indians with prediabetes have similar skeletal muscle mass and function to those with type 2 diabetes. Front Nutr. 2019;6:179.
Article PubMed PubMed Central Google Scholar
Kaga H, Tamura Y, Someya Y, Naito H, Tabata H, Kakehi S, Yamasaki N, Sato M, Kadowaki S, Suzuki R, et al. Prediabetes is an independent risk factor for sarcopenia in older men, but not in older women: the Bunkyo health study. J Cachexia Sarcopeni Muscle. 2022;13(6):2835–42.
Li S, Mao J, Zhou W. Prediabetes is associated with loss of appendicular skeletal muscle mass and sarcopenia. Front Nutr. 2023;10:1109824.
Article PubMed PubMed Central Google Scholar
Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.
Studenski SA, Peters KW, Alley DE, Cawthon PM, Mclean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol. 2014;69(5):547–58.
Wu SE, Chen WL. Calf circumference refines sarcopenia in correlating with mortality risk. Age Ageing. 2022;51(2): afab239.
Feng L, Gao Q, Hu K, Wu M, Wang Z, Chen F, Mei F, Zhao L, Ma B. Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis. J Clin Endocr Metab. 2022;107(5):1470–83.
Trierweiler H, Kisielewicz G, Hoffmann JT, Rasmussen PR, Aguiar MC, Zeghbi CBV. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr. 2018;10:25.
Article PubMed PubMed Central Google Scholar
Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q, Hu X, Tao R, Li L, Qian F, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep. 2016;6:38937.
Article CAS PubMed PubMed Central Google Scholar
Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Association of sarcopenia with both latent autoimmune diabetes in adults and type 2 diabetes: a cross-sectional study. J Diabetes Complicat. 2017;31(6):992–6.
Yang L, Smith L, Hamer M. Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing. J Epidemiol Commun Health. 2019;73(1):86–8.
Du Y, Wang X, Xie H, Zheng S, Wu X, Zhu X, Zhang X, Xue S, Li H, Hong W, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109.
Article PubMed PubMed Central Google Scholar
Hu S, Gu Y, Lu Z, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Bao X, Chi V, et al. Relationship between grip strength and prediabetes in a large-scale adult population. Am J Prev Med. 2019;56(6):844–51.
Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, Park YJ, Lim JY, Kim KW, Park KS, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40(2):140–6.
Article PubMed PubMed Central Google Scholar
Sugimoto K, Tabara Y, Ikegami H, Takata Y, Kamide K, Ikezoe T, Kiyoshige E, Makutani Y, Onuma H, Gondo Y, et al. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Invest. 2019;10(6):1471–9.
Tabara Y, Ikezoe T, Yamanaka M, Setoh K, Segawa H, Kawaguchi T, Kosugi S, Nakayama T, Ichihashi N, Tsuboyama T, et al. Advanced glycation end product accumulation is associated with low skeletal muscle mass, weak muscle strength, and reduced bone density: the Nagahama study. J Gerontol A Biol. 2019;74(9):1446–53.
Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes Targets Ther. 2019;12:1057–72.
Laaksonen MA, Harkanen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Stat Med. 2010;29(7–8):860–74.
Article CAS PubMed Google Scholar
Bank I, Gijsberts CM, Teng TK, Benson L, Sim D, Yeo P, Ong HY, Jaufeerally F, Leong G, Ling LH, et al. Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure. JACC-Heart Fail. 2017;5(1):14–24.
Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31(4):643–50.
Article PubMed PubMed Central Google Scholar
Dabak MR, Sevinc E, Tuzun S, Gun EO. Evaluation of muscle mass in obesity, prediabetes and diabetes mellitus by different equations used for the measurement of muscle mass. Diabetes Metab Syndr. 2019;13(3):2148–51.
Buffa R, Floris GU, Putzu PF, Marini E. Body composition variations in ageing. Coll Antropol. 2011;35(1):259–65.
Wada J, Nakatsuka A. Mitochondrial dynamics and mitochondrial dysfunction in diabetes. Acta Med Okayama. 2016;70(3):151–8.
Sarparanta J, Garcia-Macia M, Singh R. Autophagy and mitochondria in obesity and type 2 diabetes. Curr Diabetes Rev. 2017;13(4):352–69.
Article CAS PubMed Google Scholar
Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18–30.
Article CAS PubMed Google Scholar
Morley JE. Diabetes, sarcopenia, and frailty. Clin Geriatr Med. 2008;24(3):455–69.
Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D deficiency and sarcopenia in older persons. Nutrients. 2019;11(12):2861.
Article PubMed PubMed Central Google Scholar
Yang A, Lv Q, Chen F, Wang Y, Liu Y, Shi W, Liu Y, Wang D. The effect of vitamin D on sarcopenia depends on the level of physical activity in older adults. J Cachexia Sarcopeni. 2020;11(3):678–89.
留言 (0)